Stephan Riedmaier

eIF2B activator prevents neurological defects caused by a chronic integrated stress response

Yao Liang Wong, Lauren LeBon, Ana M. Basso et al. · eLife · 2019 · 214 citations · Full text

Clinical Neuroscience, Neuroinflammation, Neurological Defects +18

UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo

Stephan Riedmaier, Kathrin Klein, Ute Hofmann et al. · Clinical Pharmacology & Therapeutics · 2009 · 111 citations

Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes

Diana M. Feidt, Kathrin Klein, Ute Hofmann et al. · Drug Metabolism and Disposition · 2010 · 94 citations

Distinction between Human Cytochrome P450 (CYP) Isoforms and Identification of New Phosphorylation Sites by Mass Spectrometry

Gorden Redlich, Ulrich M. Zanger, Stephan Riedmaier et al. · Journal of Proteome Research · 2008 · 67 citations

Biological Mass Spectrometry, Molecular Biology, Metabolomic Profiling +17

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis

Stephan Riedmaier, Kathrin Klein, Stefan Winter et al. · Frontiers in Pharmacology · 2011 · 52 citations · Full text

Atorvastatin δ-Lactone Hydrolysis, Genetics, Atorvastatin δ-Lactone +21